| Adherence to therapy and adverse drug reactions: is there a link? C Leporini, G De Sarro, E Russo Expert opinion on drug safety 13 (sup1), 41-55, 2014 | 166 | 2014 |
| Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy M Ammendola, C Leporini, I Marech, CD Gadaleta, G Scognamillo, ... BioMed research international 2014, 2014 | 135 | 2014 |
| Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports C Palleria, C Leporini, S Chimirri, G Marrazzo, S Sacchetta, L Bruno, ... Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S66-S72, 2013 | 105 | 2013 |
| Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis F Ursini, C Leporini, F Bene, S D’Angelo, D Mauro, E Russo, G De Sarro, ... Scientific Reports 7 (1), 5346, 2017 | 75 | 2017 |
| Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials G Coppolino, C Leporini, L Rivoli, F Ursini, ED di Paola, V Cernaro, ... Pharmacological research 129, 274-294, 2018 | 70 | 2018 |
| Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases P Ventrice, C Leporini, JF Aloe, E Greco, G Leuzzi, G Marrazzo, ... Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S38-S42, 2013 | 66 | 2013 |
| Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment I Marech, C Leporini, M Ammendola, M Porcelli, CD Gadaleta, E Russo, ... Cancer letters 380 (1), 216-226, 2016 | 58 | 2016 |
| Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes C Palleria, C Leporini, F Maida, E Succurro, G De Sarro, F Arturi, E Russo Frontiers in neuroendocrinology 42, 76-92, 2016 | 55 | 2016 |
| Tumour‐associated macrophages correlate with microvascular bed extension in colorectal cancer patients I Marech, M Ammendola, R Sacco, G Sammarco, V Zuccala, N Zizzo, ... Journal of cellular and molecular medicine 20 (7), 1373-1380, 2016 | 47 | 2016 |
| Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: a systematic review and meta-analysis C Leporini, A Pisano, E Russo, G de Sarro, G Coppolino, D Bolignano Pharmacological research 107, 315-332, 2016 | 45 | 2016 |
| Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis C Giofrè, F Scicchitano, C Palleria, C Mazzitello, M Ciriaco, L Gallelli, ... Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S55-S60, 2013 | 42 | 2013 |
| Targeting mast cells in gastric cancer with special reference to bone metastases C Leporini, M Ammendola, I Marech, G Sammarco, R Sacco, ... World journal of gastroenterology: WJG 21 (37), 10493, 2015 | 24 | 2015 |
| C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients I Marech, M Ammendola, C Leporini, R Patruno, M Luposella, N Zizzo, ... Oncotarget 9 (8), 7918, 2018 | 21 | 2018 |
| A comprehensive safety evaluation of trabectedin and drug–drug interactions of trabectedin-based combinations C Leporini, M Patane, F Saullo, P Rende, L Gallelli, ED Di Paola, ... BioDrugs 28, 499-511, 2014 | 21 | 2014 |
| Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapy M Ammendola, C Leporini, M Luposella, R Sacco, G Sammarco, E Russo, ... Current stem cell research & therapy 10 (2), 181-187, 2015 | 20 | 2015 |
| Drug-drug interactions: antiretroviral drugs and recreational drugs O Staltari, C Leporini, B Caroleo, E Russo, A Siniscalchi, G De Sarro, ... Recent Patents on CNS Drug Discovery (Discontinued) 9 (3), 153-163, 2014 | 17 | 2014 |
| Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review C Leporini, F Saullo, G Filippelli, A Sorrentino, M Lucia, G Perri, ... Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S78-S85, 2013 | 17 | 2013 |
| Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria … C Palleria, L Iannone, C Leporini, R Citraro, A Manti, M Caminiti, ... PLoS One 13 (10), e0205134, 2018 | 13 | 2018 |
| Insulin-sensiting effects of tumor necrosis factor alpha inhibitors in rheumatoid arthritis: a systematic review and meta-analysis C Leporini, E Russo, S D'Angelo, F Arturi, G Tripepi, R Peluso, ... Reviews on Recent Clinical Trials 13 (3), 184-191, 2018 | 13 | 2018 |
| Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European … C Leporini, G Marrazzo, L Mumoli, S Esposito, L Gallelli, G Mangano, ... Expert opinion on drug safety 16 (5), 515-522, 2017 | 12 | 2017 |
Emilio RussoUniversity Magna Grecia of CatanzaroVerified email at unicz.it
